Chemours co president Michael Foley buys $29,999 in stock

Chemours Company President Michael Foley made a notable stock purchase on August 7, 2026, acquiring 1,934.2313 shares at a price of $15.51 to $15.54 per share, amounting to $29,999. This investment brings Mr. Foley's total ownership of Chemours common stock to 80,777.2308 shares, encompassing directly held shares, restricted stock units, and dividend equivalent units.

The transaction took place at a time when Chemours shares were trading at $15.85, reflecting a 22% decrease over the past six months, despite a 36% increase year-to-date. Despite the overall stock market performance, the company's shares are considered slightly overvalued based on InvestingPro analysis, placing Chemours on the Most Overvalued list.

Chemours offers a dividend yield of 2.21% and holds a market capitalization of $2.3 billion. Investors can find further analysis through InvestingPro Tips and a Pro Research Report. In light of recent news, Chemours reported second-quarter 2026 earnings that fell short of expectations, reporting $0.42 per share on $1.59 billion in revenue, failing to meet analysts' estimates of $0.50 per share and $1.66 billion in sales.

UBS recently downgraded Chemours from Buy to Neutral, adjusting its price target to $18.00, citing concerns about potential market share loss and destocking issues anticipated within 2026, particularly within Chemours’ refrigerant business.